Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
Clinical trial NCT07170293 · RECRUITING
Trial details
- NCT number
- NCT07170293
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-08-31
- Primary completion
- 2027-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.